Literature DB >> 29172845

Temporal retinal thinning and the diagnosis of Alport syndrome and Thin basement membrane nephropathy.

Yan Chen1, Deb Colville1, Francesco Ierino2, Andrew Symons3, Judy Savige1.   

Abstract

BACKGROUND AND OBJECTIVES: Alport syndrome is an inherited disease characterized by renal failure, hearing loss, and ocular abnormalities, including temporal retinal thinning. This study compared retinal thinning in Alport syndrome and other renal diseases.
METHODS: Alport syndrome was diagnosed on renal biopsy and genetic testing. Subjects underwent optical coherence tomography (OCT) (Spectralis OCT, Heidelberg Instruments). Retinal thinning was determined from horizontal macular OCT scans through the foveal center using the formula: Temporal thickness index (TTI) = (nasal - temporal thickness) ÷ nasal thickness × 100%, and compared with the normal range for each age group. Statistical analysis was performed using Student's t test, Mann-Whitney U test, and ROC analysis (SPPS, IBM).
RESULTS: The mean temporal retinal thickness index was 12.4 ± 5.2% in men (n = 19) and 7.4 ± 1.4% in women (n = 28) with X-linked Alport syndrome; 13.1 ± 4.5% (n = 4) in recessive disease; 6.4 ± 2.2% (n = 5) in Thin basement membrane nephropathy; and 6.3 ± 3.3% (n = 14) in other renal diseases. Thinning was worse in men than women with X-linked disease (p < 0.01), and worse in men who developed early onset renal failure (R2 = 0.75). Temporal retinal thinning was 84% sensitive for men with X-linked Alport syndrome and 67% specific (AUC = 0.83) compared with other renal diseases.
CONCLUSIONS: Retinal temporal thinning is diagnostic for X-linked Alport syndrome in men and distinguishes them this condition from Thin basement membrane nephropathy, but only in men (p = 0.002). Temporal retinal thinning may also identify men and women with the rarer autosomal recessive disease.

Entities:  

Keywords:  Alport syndrome; Thin basement membrane nephropathy; basement membrane; optical coherence tomography; retina

Mesh:

Substances:

Year:  2017        PMID: 29172845     DOI: 10.1080/13816810.2017.1401088

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  8 in total

1.  Alport syndrome: deducing the mode of inheritance from the presence of haematuria in family members.

Authors:  Judy Savige
Journal:  Pediatr Nephrol       Date:  2018-11-30       Impact factor: 3.714

2.  Guidelines for Genetic Testing and Management of Alport Syndrome.

Authors:  Judy Savige; Beata S Lipska-Zietkiewicz; Elizabeth Watson; Jens Michael Hertz; Constantinos Deltas; Francesca Mari; Pascale Hilbert; Pavlina Plevova; Peter Byers; Agne Cerkauskaite; Martin Gregory; Rimante Cerkauskiene; Danica Galesic Ljubanovic; Francesca Becherucci; Carmela Errichiello; Laura Massella; Valeria Aiello; Rachel Lennon; Louise Hopkinson; Ania Koziell; Adrian Lungu; Hansjorg Martin Rothe; Julia Hoefele; Miriam Zacchia; Tamara Nikuseva Martic; Asheeta Gupta; Albertien van Eerde; Susie Gear; Samuela Landini; Viviana Palazzo; Laith Al-Rabadi; Kathleen Claes; Anniek Corveleyn; Evelien Van Hoof; Micheel van Geel; Maggie Williams; Emma Ashton; Hendica Belge; Elisabet Ars; Agnieszka Bierzynska; Concetta Gangemi; Alessandra Renieri; Helen Storey; Frances Flinter
Journal:  Clin J Am Soc Nephrol       Date:  2021-12-20       Impact factor: 8.237

3.  Temporal retinal thinning might be an early diagnostic indicator in male pediatric X-linked Alport syndrome.

Authors:  Rui-Lin Zhu; Liang Zhao; Xiao-Peng Gu; Ya-Di Zhang; Fang Wang; Yan-Qin Zhang; Liu Yang
Journal:  Int J Ophthalmol       Date:  2022-07-18       Impact factor: 1.645

4.  Features of Autosomal Recessive Alport Syndrome: A Systematic Review.

Authors:  Jiwon M Lee; Kandai Nozu; Dae Eun Choi; Hee Gyung Kang; Ii-Soo Ha; Hae Ii Cheong
Journal:  J Clin Med       Date:  2019-02-03       Impact factor: 4.241

Review 5.  Molecular Basis, Diagnostic Challenges and Therapeutic Approaches of Alport Syndrome: A Primer for Clinicians.

Authors:  Raquel Martínez-Pulleiro; María García-Murias; Manuel Fidalgo-Díaz; Miguel Ángel García-González
Journal:  Int J Mol Sci       Date:  2021-10-14       Impact factor: 5.923

6.  Characterization of Choriocapillaris and Choroidal Abnormalities in Alport Syndrome.

Authors:  Maria Vittoria Cicinelli; Markus Ritter; Hassan Tausif; Cybele Ghossein; Constantin Aschauer; Franco Laccone; Mato Nagel; Lee M Jampol; Manjot K Gill
Journal:  Transl Vis Sci Technol       Date:  2022-03-02       Impact factor: 3.283

Review 7.  Genotype-Phenotype Correlations for Pathogenic COL4A3-COL4A5 Variants in X-Linked, Autosomal Recessive, and Autosomal Dominant Alport Syndrome.

Authors:  Judy Savige; Mary Huang; Marina Shenelli Croos Dabrera; Krushnam Shukla; Joel Gibson
Journal:  Front Med (Lausanne)       Date:  2022-05-06

Review 8.  Heterozygous Pathogenic COL4A3 and COL4A4 Variants (Autosomal Dominant Alport Syndrome) Are Common, and Not Typically Associated With End-Stage Kidney Failure, Hearing Loss, or Ocular Abnormalities.

Authors:  Judy Savige
Journal:  Kidney Int Rep       Date:  2022-06-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.